Investors who lost money on Baxter International, Inc.(BAX) should contact Levi & Korsinsky about pending Class Action – BAX GlobeNewswire December 12, 2025 NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. (“Baxter International, Inc.” or the “Company”) (NYSE: BAX) of a class action securities lawsuit. […]
Skye Bioscience, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – SKYE GlobeNewswire December 12, 2025 NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. (“Skye Bioscience, Inc.” or the “Company”) (NASDAQ: SKYE) of a class action securities
MoonLake Immunotherapeutics Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MLTX GlobeNewswire December 12, 2025 NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) of a class action securities lawsuit. CLASS DEFINITION: The
https://mma.prnewswire.com/media/331912/fmc_corporation_logo.jpg FMC Corporation (NYSE: FMC) announced today that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on January 15, 2026, to shareholders of record as of the close of business on December 31, 2025. About FMC FMC Corporation is a global agricultural sciences company dedicated to helping growers
Neuberger Berman Real Estate Securities Income Fund Inc. (NYSE American: NRO) (the “Fund”) has announced that Archena Alagappan, Senior Vice President, has been named associate portfolio manager of the Fund, effective December 12, 2025. https://mma.prnewswire.com/media/75472/neuberger_berman_group_llc_logo.jpg About Neuberger Berman Neuberger Berman is an employee-owned, private, independent investment manager founded in 1939 with over 2,900 employees in
HuntingtonBancshares Incorporated announced that the Board of Directors declared and set aside a quarterly cash dividend on the company's 5.70% Series I Non-Cumulative Perpetual Preferred Stock (Nasdaq: HBANM) of $356.25 per share (equivalent to $0.35625 per depositary share) payable March 2, 2026, to shareholders of record on February 15, 2026. https://mma.prnewswire.com/media/2730277/Huntington_Exception_Logo.jpg About HuntingtonHuntington Bancshares Incorporated
(NASDAQ:GRAN), Hong Kong, Dec. 12, 2025 (GLOBE NEWSWIRE) — GRANDE GROUP LIMITED (“GRAN” or the “Company”) (Nasdaq: GRAN), a Hong Kong-based financial services provider which principally engages in the provision of corporate finance advisory services and IPO sponsor services through its Hong Kong subsidiary, Grande Capital Limited, today announced its unaudited financial results for the
(NASDAQ:ZVRA), CELEBRATION, Fla., Dec. 12, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that the Company has granted options to purchase an aggregate of 53,000 shares of the Company's common stock (the “Inducement Awards”) to
(NasdaqGM:FLY), NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Firefly Aerospace Inc. (“Firefly Aerospace Inc.” or the “Company”) (NASDAQ: FLY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Firefly Aerospace Inc. investors who were adversely affected by alleged securities
(NYSE:TEVA),(TASE:TEVA.TA),(TASE:TEVA), TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter 2025 financial results on Wednesday, January 28, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast